Loprox - CICLOPIROX
Navigation: NDC > Supplier starting with: M > MEDICIS PHARMACEUTICAL CORP| Field | Value |
|---|---|
| NDC Code: | 99207-013 |
| Proprietary Name: | Loprox |
| Suffix: | |
| Non-Proprietary Name: | CICLOPIROX |
| Dosage Form: | GEL |
| Method: | TOPICAL |
| Original Marketing Date: | 01-05-2005 |
| End of Marketing: | 28-02-2014 |
| Category Name: | NDA |
| Application Number: | NDA020519 |
| Labeler: | MEDICIS PHARMACEUTICAL CORP |
| Substance Name: | CICLOPIROX |
| Active Numerator Strength: | 7.7 |
| Active Ingredient Unit: | mg/g |
| Pharm Classes: | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |
| DEA Schedule: |